Biofactory Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Piotr Karp

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership21.8%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

A Look At The Intrinsic Value Of Biofactory S.A. (WSE:BFC)

Nov 04
A Look At The Intrinsic Value Of Biofactory S.A. (WSE:BFC)

Should You Be Adding Biofactory (WSE:BFC) To Your Watchlist Today?

Jul 11
Should You Be Adding Biofactory (WSE:BFC) To Your Watchlist Today?

Calculating The Fair Value Of Biofactory S.A. (WSE:BFC)

Feb 03
Calculating The Fair Value Of Biofactory S.A. (WSE:BFC)

CEO

Piotr Karp

less than a year

Tenure

Mr. Piotr Karp is President of the Management Board of Biofactory S.A. since May 2024 and was its Chairman of the Supervisory Board from November 2023 to May 2024. He is graduate of the WNiG faculty of the...


Board Members

NamePositionTenureCompensationOwnership
Marek Karp
Vice-Chairman of the Supervisory Boardless than a yearno data17.09%
PLN 1.5m
Kamil Karp
Chairman of the Supervisory Boardless than a yearno data17.47%
PLN 1.5m
Agnieszka Karp
Member of the Supervisory Boardless than a yearno datano data
Witold Wszolek
Member of the Supervisory Boardless than a yearno datano data

0.7yrs

Average Tenure

Experienced Board: BFC's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/14 23:06
End of Day Share Price 2024/04/17 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biofactory S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution